NobleBlocks
Public

An overview of resistance to chemotherapy in osteosarcoma and future perspectives.

Published in Cancer drug resistance (Alhambra, Calif.) • Jan 1, 2022
Authors:
Dorian Yarih Garcia-Ortega
,
Sara Aileen Cabrera-Nieto
,
Haydee Sarai Caro-Sánchez

Abstract

Osteosarcoma (OS) is the most common type of bone sarcoma. Despite the availability of multimodal treatment with surgery and chemotherapy, the clinical results remain unsatisfactory. The main reason for the poor outcomes in patients with OS is the development of resistance to methotrexate, cisplatin...

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!